Skip to Main Content

NISH (NITAG Support Hub) 7: Mpox vaccines: Other WHO papers and partner publications

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of MPox vaccines to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Mpox outbreak

 

Partnership for International Vaccine Initiatives (PIVI); Taskforce for Global Health (TFGH); Centers for Disease Control and Prevention (CDC). (2025). MPOx Evidence Brief for NITAGs.  Available at:   ld.php

NEW!! 

WHO. (2025). Frequently Asked Questions (FAQ) on use of fractional dosing with intradermal administration of mpox MVA-BN vaccine in the context of vaccine supply-constrained outbreak response. https://cdn.who.int/media/docs/default-source/immunization/mpox/who_faq_intradermal_fractional_dosing_mva-bn_vaccine.pdf?sfvrsn=ab124257_3

WHO. More resources here:https://www.who.int/health-topics/mpox#tab=tab_1

WHO Mpox vaccines FAQ  https://www.who.int/news-room/questions-and-answers/item/mpox-vaccines

WHO. Mpox outbreak.
https://www.who.int/emergencies/situations/mpox-outbreak

WHO. 2024. WHO Director-General declares Mpox outbreak a public health emergency of international concern.

 WHO Mpox (monkeypox) outbreak; 2022. Avalaible from: https://www.who.int/emergencies/situations/monkeypox-oubreak-2022.

WHO recommends new name for monkeypox disease. Avaiilable from: https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease.

World Health Organization. (2023). Responding to the global mpox outbreak: ethics issues and considerations: a policy brief, 19 July 2023 (No. WHO/Mpox/Outbreak_response/Ethics/2023.1). World Health Organization. https://iris.who.int/bitstream/handle/10665/371405/WHO-Mpox-Outbreak-response-Ethics-2023.1-eng.pdf?sequence=1

World Health Organization. (2024). Regional Mpox Bulletin: 11 August 2024. Regional Mpox Bulletin: 11 August 2024  

World Health Organization (2024). Strategic framework for enhancing prevention and control of mpox 2024-2027 . Strategic framework for enhancing prevention and control of mpox 2024-2027 

World Health Organization. (2024). Risk communication and community engagement readiness and response toolkit: mpox . Risk communication and community engagement readiness and response toolkit: mpox 

Lewis, R. F., Kuppalli, K., Hoxha, A., & Doherty, M. C. (2023). Emergency committee recommendations on mpox–what’s next?. Bulletin of the World Health Organization101(5), 300. https://iris.who.int/bitstream/handle/10665/367568/PMC10140684.pdf?sequence=1&isAllowed=y

World Health Organization. (2024). Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 20 March 2024. In Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 20 March 2024.WHO-MPX-Surveillance-2024.1-eng.pdf (‎451.9Kb)‎

 

NITAG Resource Centre

Australian technical advisory Group on immunisation (ATAGI). Clinical guidance on the use of vaccines for Prevention of Mpox in 2024.

https://www.nitag-resource.org/sites/default/files/2024-12/atagi-clinical-guidance-on-the-use-of-vaccines-for-the-prevention-of-mpox.pdf
 

WHO. Mpox: Multi-country External Situation Report no.45

https://cdn.who.int/media/docs/default-source/documents/emergencies/mpox-sitrep_-45.pdf?sfvrsn=67f9f699_1&download=true

National Advisory Committee on Immunization (NACI). (2024)  NACI Rapid Response: Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada Ottawa (ON): Government of Canada: Government of Canada; 2022 Nov 09  https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-imvamune-monkeypox.html.

Akter, F., Hasan, T. B., Alam, F., Das, A., Afrin, S., Maisha, S., ... & KM, S. U. R. (2023). Effect of prior immunisation with smallpox vaccine for protection against human Mpox: a systematic review. Reviews in Medical Virology33(4), e2444. https://doi.org/10.1002/rmv.2444

Malone, S. M., Mitra, A. K., Onumah, N. A., Brown, A., Jones, L. M., Tresvant, D. C., ... & Iseguede, F. O. (2023). Safety and efficacy of post-eradication smallpox vaccine as an mpox vaccine: a systematic review with meta-analysis. International Journal of Environmental Research and Public Health20(4), 2963.https://doi.org/10.3390/ijerph20042963

STIKO. 2023. Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023. https://www.rki.de/EN/Content/infections/Vaccination/recommandations/04_23_englisch.pdf?__blob=publicationFile

SAGE. 2022. Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022. https://www.who.int/publications/i/item/WHO-MPX-Immunization